...
首页> 外文期刊>European journal of gastroenterology and hepatology >Hepatitis C virus treatment by direct-acting antivirals in successfully treated hepatocellular carcinoma and possible mutual impact
【24h】

Hepatitis C virus treatment by direct-acting antivirals in successfully treated hepatocellular carcinoma and possible mutual impact

机译:丙型肝炎病毒通过直接治疗的肝细胞癌和可能的相互影响进行直接作用抗病毒

获取原文
获取原文并翻译 | 示例
           

摘要

Background and aims Treatment of hepatitis C virus (HCV) after successfully treated hepatocellular carcinoma (HCC) becomes possible with the introduction of direct-acting antivirals because of their favorable efficacy, safety, and short period of treatment. Few data are available on the results of treatment using different direct-acting antiviral regimens in successfully treated HCC and a lot of debate about its role in tumor recurrence.
机译:背景和AIMS治疗丙型肝炎病毒(HCV)在成功处理的肝细胞癌(HCC)之后,由于其良好的疗效,安全性和短期治疗,因此可以引入直接作用抗病毒药物。 在成功处理的HCC中使用不同直接的直接抗病毒方案的治疗结果可以获得少数数据以及关于其在肿瘤复发中的作用的大量争论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号